Losartan potassium membrane controlled-release pellet capsule

A technology of losartan potassium film and sustained-release pellets, which can be applied to medical preparations of non-active ingredients, cardiovascular system diseases, organic active ingredients, etc., and can solve the problems of membrane aging and release decline

Inactive Publication Date: 2013-07-24
内蒙古天衡医院管理有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In order to solve the problem of release decline caused by film aging of losartan potassium film-controlled sustained-release pellets prepared by aqueous dispersion coating, the present invention provides a film-controlled film that can maintain stable release performance throughout the validity period. Losartan Potassium Sustained-release Pellet Capsule Capsules are characterized in that the core of the pellet contains low-substituted hydroxypropyl cellulose with high water-swellability, and the sustained-release coating film is deformed by water-absorbing swelling, thereby offsetting the film aging

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Losartan potassium membrane controlled-release pellet capsule
  • Losartan potassium membrane controlled-release pellet capsule
  • Losartan potassium membrane controlled-release pellet capsule

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The losartan potassium slow-release pellet capsule of embodiment 1 common ball core

[0029] 1. Prescription

[0030] 1. Pill core prescription (1000 capsules)

[0031]

[0032] 2. Prescription of sustained-release film coating solution

[0033]

[0034]

[0035] 3. No. 0 stomach-soluble gelatin capsule shell 1000 capsules

[0036] Second, the preparation process:

[0037] 1. Ball core preparation process:

[0038] (1) Losartan potassium is passed through a 60 mesh sieve;

[0039](2) Losartan Potassium and Microcrystalline Cellulose PH101 are taken by weighing recipe quantity, put in wet granulator and mix homogeneously;

[0040] (3) soft material made of 1% sodium carboxymethyl cellulose aqueous solution;

[0041] (4) Extrude on the extruder, the screen aperture is 1.0mm, and the extrusion speed is 20-30rpm;

[0042] (5) spheronization, the spheronization speed is 900~1000rpm, drying in the fluidized bed;

[0043] (6) Sieve, and take ball cores between...

Embodiment 2

[0069] Example 2 Losartan Potassium Sustained-release Pellet Capsules Containing 10% Low-substituted Hypromellose

[0070] 1. Prescription

[0071] 1. Pill core prescription (1000 capsules)

[0072]

[0073] 2. Prescription of sustained-release film coating solution: same as in Example 1

[0074] 3. No. 0 stomach-soluble gelatin capsule shell 1000 capsules

[0075] Second, the preparation process:

[0076] 1. Ball core preparation process:

[0077] (1) Losartan potassium is passed through a 60 mesh sieve;

[0078] (2) Losartan Potassium, microcrystalline cellulose PH101, low-substituted hydroxypropyl cellulose are taken by weighing recipe quantity, put in wet granulator and mix homogeneously;

[0079] (3) soft material made of 1% sodium carboxymethyl cellulose aqueous solution;

[0080] (4) Extrude on the extruder, the screen aperture is 1.0mm, and the extrusion speed is 20-30rpm;

[0081] (5) spheronization, the spheronization speed is 900~1000rpm, drying in the flu...

Embodiment 3

[0100] Example 3 Losartan Potassium Sustained-release Pellet Capsules Containing 20% ​​Low-substituted Hypromellose

[0101] 1. Prescription

[0102] 1. Pill core prescription (1000 capsules)

[0103]

[0104] 2. Prescription of sustained-release film coating solution: same as in Example 1

[0105] 3. No. 0 stomach-soluble gelatin capsule shell 1000 capsules

[0106] Second, the preparation process:

[0107] 1. Ball core preparation process: the same as in Example 2

[0108] 2. Preparation process of sustained-release film coating solution:

[0109] Same as Example 1

[0110]3. Coating (sustained release film):

[0111] The ball core is placed in a fluidized bed for coating, and the weight gain of the coating film is controlled, and the weight gain of the coating is 21.3% and 27.5%.

[0112] 4, heat treatment: with embodiment 1

[0113] 5. Fill capsules

[0114] The coated micropills are filled into capsules to obtain losartan potassium sustained-release micropill ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a losartan potassium membrane controlled-release pellet capsule. The controlled-release film of the pellet adopts Eurdragit NE 30D as a film forming material, the core of the controlled-release pellet contains high-expansibility low-substituted hydroxypropylcellulose and a pharmaceutically-acceptable excipient commonly used for controlled-release pellets, and optimally, the excipient is microcrystalline cellulose, wherein the weight percentage of the low-substituted hydroxypropylcellulose in the core of the controlled-release pellet is 10-40%. The controlled-release film of the controlled-release pellet includes the Eurdragit NE 30D and an anti-adherent talcum powder, the optimal ratio of the Eurdragit NE 30D to the talcum powder is 30:6, and the optimal coating weight gain is 19-36%. The core will obviously expand after absorbing water because of the containment of the low-substituted hydroxypropylcellulose highly expanding after contacting with water, so the controlled-release film is stretched, the thickness of the film is thinned, the apertures of water-pervious micro-pores are increased, the permeability is good, and the permeability decrease caused by film ageing is compensated, thereby the middle and later stage release speed is basically constant, the last stage residue is small, and a stable release performance is always maintained prior to the expiration date.

Description

technical field [0001] The invention relates to a losartan potassium membrane-controlled sustained-release pellet capsule, in particular to a losartan potassium membrane-controlled sustained-release pellet capsule containing low-substituted hydroxypropyl cellulose in the pellet core, belonging to the field of pharmaceutical preparations . Background technique [0002] Losartan potassium is an angiotensin II receptor (AT1 type) antagonist, which can block various pharmacological effects of endogenous and exogenous angiotensin II by selectively acting on AT1 receptors (Including promoting vasoconstriction, aldosterone release, etc.), for the treatment of high blood pressure. The basic clinical requirement for this type of drug is that it can control symptoms for a long time. [0003] Losartan Potassium is dissolved in water, and Merck & Co. has launched Losartan Potassium Common Tablets (trade name: Cozaar) administered once a day. Losartan potassium is a prodrug with a sho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/52A61K31/4178A61K47/32A61K47/38A61P9/12
Inventor 姜庆伟狄媛吕玉珠唐亚坤刘俊轶
Owner 内蒙古天衡医院管理有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap